Neurochemical dementia diagnostics in Alzheimer's disease: where are we now and where are we going? (Q37912199)

25 August 2017

1 reference

title

Neurochemical dementia diagnostics in Alzheimer's disease: where are we now and where are we going? (English)

1 reference

25 August 2017

0 references

0 references

2

1 reference

25 August 2017

1

Piotr Lewczuk

1 reference

25 August 2017

publication date

1 August 2011

1 reference

Expert Review of Proteomics

25 August 2017

published in

1 reference

25 August 2017

volume

8

1 reference

25 August 2017

issue

4

1 reference

25 August 2017

page(s)

447-458

1 reference

Evaluation and use of diagnostic tests in Alzheimer's disease

25 August 2017

cites work

1 reference

Therapeutic approaches to Alzheimer's disease

21 January 2018

1 reference

Dynamics of brain-derived proteins in cerebrospinal fluid

21 January 2018

1 reference

The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor

21 January 2018

1 reference

The amyloid precursor protein gene: a neuropeptide gene with diverse functions in the central nervous system

21 January 2018

1 reference

Evidence that the 42- and 40-amino acid forms of amyloid beta protein are generated from the beta-amyloid precursor protein by different protease activities

21 January 2018

1 reference

The intramembrane cleavage site of the amyloid precursor protein depends on the length of its transmembrane domain

21 January 2018

1 reference

Truncated beta-amyloid peptide channels provide an alternative mechanism for Alzheimer's Disease and Down syndrome

21 January 2018

1 reference

The amyloid-beta (Abeta) peptide pattern in cerebrospinal fluid in Alzheimer's disease: evidence of a novel carboxyterminally elongated Abeta peptide

21 January 2018

1 reference

Neurochemical diagnosis of Alzheimer's dementia by CSF Abeta42, Abeta42/Abeta40 ratio and total tau.

21 January 2018

1 reference

Highly conserved and disease-specific patterns of carboxyterminally truncated Abeta peptides 1-37/38/39 in addition to 1-40/42 in Alzheimer's disease and in patients with chronic neuroinflammation.

21 January 2018

1 reference

CSF total tau, Abeta42 and phosphorylated tau protein as biomarkers for Alzheimer's disease

21 January 2018

1 reference

Molecular biology of Alzheimer's dementia and its clinical relevance to early diagnosis and new therapeutic strategies.

21 January 2018

1 reference

Neurochemical dementia diagnostics: State of the art and research perspectives

21 January 2018

1 reference

Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease.

21 January 2018

1 reference

Beta-amyloid peptides in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.

21 January 2018

1 reference

Low cerebrospinal fluid beta-amyloid 42 in patients with acute bacterial meningitis and normalization after treatment

21 January 2018

1 reference

Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF.

21 January 2018

1 reference

High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype.

21 January 2018

1 reference

Structural principles of tau and the paired helical filaments of Alzheimer's disease

21 January 2018

1 reference

The cytoskeleton in neurodegenerative diseases

21 January 2018

1 reference

Functions and malfunctions of the tau proteins

21 January 2018

1 reference

Developmental expression of tau proteins in the chicken and rat brain: rapid down-regulation of a paired helical filament epitope in the rat cerebral cortex coincides with the transition from immature to adult tau isoforms.

21 January 2018

1 reference

Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease

21 January 2018

1 reference

Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke

21 January 2018

1 reference

Defective brain microtubule assembly in Alzheimer's disease

21 January 2018

1 reference

Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology

21 January 2018

1 reference

Levels of nonphosphorylated and phosphorylated tau in cerebrospinal fluid of Alzheimer's disease patients : an ultrasensitive bienzyme-substrate-recycle enzyme-linked immunosorbent assay

21 January 2018

1 reference

Significance and mechanism of Alzheimer neurofibrillary degeneration and therapeutic targets to inhibit this lesion

21 January 2018

1 reference

Tau protein phosphorylated at threonine 181 in CSF as a neurochemical biomarker in Alzheimer's disease: original data and review of the literature

21 January 2018

1 reference

CSF phosphorylated tau is a possible marker for discriminating Alzheimer's disease from dementia with Lewy bodies. Phospho-Tau International Study Group

21 January 2018

1 reference

Large-scale, multicenter study of cerebrospinal fluid tau protein phosphorylated at serine 199 for the antemortem diagnosis of Alzheimer's disease

21 January 2018

1 reference

CSF phosphorylated tau protein and mild cognitive impairment: a prospective study

21 January 2018

1 reference

Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study

21 January 2018

1 reference

Effects of endogenous beta-amyloid overproduction on tau phosphorylation in cell culture

21 January 2018

1 reference

Phosphorylation of Tau at S422 is enhanced by Abeta in TauPS2APP triple transgenic mice.

21 January 2018

1 reference

Alzheimer's disease-do tauists and baptists finally shake hands?

21 January 2018

1 reference

Neurochemical dementia diagnostics: a simple algorithm for interpretation of the CSF biomarkers

21 January 2018

1 reference

International quality control survey of neurochemical dementia diagnostics.

21 January 2018

1 reference

Cerebrospinal fluid markers for prediction of Alzheimer's disease

21 January 2018

1 reference

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study

21 January 2018

1 reference

Multiplexed quantification of dementia biomarkers in the CSF of patients with early dementias and MCI: a multicenter study

21 January 2018

1 reference

Biomarkers as predictors for conversion from mild cognitive impairment to Alzheimer-type dementia: implications for trial design

21 January 2018

1 reference

Effects of processing and storage conditions on amyloid beta (1-42) and tau concentrations in cerebrospinal fluid: implications for use in clinical practice

21 January 2018

1 reference

Standardization of measurement of beta-amyloid(1-42) in cerebrospinal fluid and plasma

21 January 2018

1 reference

Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study

21 January 2018

1 reference

Correlations between soluble α/β forms of amyloid precursor protein and Aβ38, 40, and 42 in human cerebrospinal fluid

21 January 2018

1 reference

Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease

21 January 2018

1 reference

Brain to plasma amyloid-beta efflux: a measure of brain amyloid burden in a mouse model of Alzheimer's disease

21 January 2018

1 reference

Capillary and arterial cerebral amyloid angiopathy in Alzheimer's disease: defining the perivascular route for the elimination of amyloid beta from the human brain

21 January 2018

1 reference

Elevated abeta42 in skeletal muscle of Alzheimer disease patients suggests peripheral alterations of AbetaPP metabolism.

21 January 2018

1 reference

Plasma Abeta(1-40) and Abeta(1-42) and the risk of dementia: a prospective case-cohort study

21 January 2018

1 reference

Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease

21 January 2018

1 reference

Amyloid-associated depression: a prodromal depression of Alzheimer disease?

21 January 2018

1 reference

Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis

21 January 2018

1 reference

Amyloid beta peptides in plasma in early diagnosis of Alzheimer's disease: A multicenter study with multiplexing.

21 January 2018

1 reference

Multiplexed particle-based flow cytometric assays

21 January 2018

1 reference

Simultaneous quantitation of 15 cytokines using a multiplexed flow cytometric assay

21 January 2018

1 reference

Simultaneous measurement of beta-amyloid(1-42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology

21 January 2018

1 reference

A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's disease

21 January 2018

1 reference

Inter-laboratory variation in cerebrospinal fluid biomarkers for Alzheimer's disease: united we stand, divided we fall

21 January 2018

1 reference

Vergleichende Sensitivität der neurochemischen Demenzdiagnostik im Liquor und rCBF im99mTc-SPECT bei Patienten mit Alzheimerdemenz

21 January 2018

1 reference

Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt–Jakob disease

21 January 2018

1 reference

Effect of Sample Collection Tubes on Cerebrospinal Fluid Concentrations of Tau Proteins and Amyloid Peptides

21 January 2018

1 reference

Tau protein isoforms, phosphorylation and role in neurodegenerative disorders11These authors contributed equally to this work

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/EPR.11.37

1 reference

25 August 2017

1 reference